【Intro】Cancerfree Biotech Ltd. - TAcc+

撰文新聞中心
日期2021-07-13
Cancerfree Biotech Ltd. - TAcc+

Company Introduction

Focusing on the analysis of circulating tumor cells (CTCs), CancerFree is committed to developing a more competitive and personalized anti-cancer drug testing service. With its three business philosophies of "Doing the Right Thing", "Putting Patient First", and "Leading with Exceptional Ideas", CancerFree continues to develop and improve biomedical technologies to bring the results of laboratory research and development to human life and help patients and physicians.

Brief description of main products or services 

Up to 70% of cancer patients can’t find their precision medicine,  with the effectiveness of precision medicine guided by precision medicine scaling that up to 62%. Cancerfree Biotech Ltd. is based on innovative precision medicine and focuses on in vitro amplification of circulating tumor cells (CTCs) and the related analysis. Our proprietary platform E.V.A. (Ex Vivo Avatar) can fast expand patient-derived cancer cells from using their blood sample and provide patients a precision drug screening report (call EVA Select)for developing strategies against cancers at all stages. EVA Select is a liquid biopsy personalized anti-cancer drug testing for developing strategies against cancers.